🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Pulmonary TB

DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary Tuberculosis NCT06585358n/a2 sites📍 Linköping📍 Stockholm Karolinska Institutet · Tests: MIPD A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis NCT07209761Phase 342 sites📍 Beijing📍 Fuzhou📍 Shenzhen Otsuka Pharmaceutical Development & Commercialization, Inc. · Tests: Bedaquiline, Quabodepistat, Pretomanid, Moxifloxacin, Linezolid A Trial to Compare Nebulized Amphotericin B and Nebulized Normal Saline as Maintenance in Patients With Chronic Pulmonary Aspergillosis NCT06447402Phase 31 site📍 Chandigarh Post Graduate Institute of Medical Education and Research, … · Tests: Normal saline, Amphotericin B deoxycholate Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and Vomiting NCT07271225NA1 site📍 Jakarta Universitas Indonesia · Tests: Press Needle, Sham Press Needle Effect of Peer-led Educational Intervention on Treatment Outcomes Among Adults With Drug-susceptible Pulmonary Tuberculosis in South Omo and Ari Zone, Southern Ethiopia NCT07387601NA1 site📍 Jinka Bahirdar University · Tests: peer-led education Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis NCT05473520Phase 36 sites📍 Kota Kinabalu📍 Kota Kinabalu📍 Kota Kinabalu National University Hospital, Singapore · Tests: Doxycycline, Placebo ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74 NCT06714513Phase 14 sites📍 Gwangmyeong📍 Seoul📍 Seoul Quratis Inc. · Tests: QTP101, Placebo Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure) NCT07164742NA2 sites📍 Mangalore📍 Pune Johns Hopkins University · Tests: 8 week (short arm) Intervention - pulmonary rehabilitation, 24 week (long arm) Intervention - pulmonary rehabilitation Effects of Adjunct Omega-3 Long Chain Polyunsaturated Fatty Acids in Pulmonary Tuberculosis Patient: an Early Bactericidal Activity and Inflammatory Trial NCT07118059Phase 21 site📍 Klerksdorp North-West University, South Africa · Tests: Omega-3 (EPA+DHA), Placebo PanACEA - STEP2C -01 NCT05807399Phase 210 sites📍 Lambaréné📍 Blantyre📍 Maputo Michael Hoelscher · Tests: BTZ-043, Rifampicin, Isoniazid, Pyrazinamide, Moxifloxacin LIFE-TB ; Long-Term Impacts on Lung Health and Life After Tuberculosis in Korea NCT06946784n/a1 site📍 Seoul Yonsei University Remimazolam for Bronchoscopy in High-Risk Patients NCT07395596Phase 42 sites📍 Hangzhou📍 Shaoxing First Affiliated Hospital of Zhejiang University · Tests: propofol and alfentanil, remimazolam combined with propofol and alfentanil Channa Striata and Curcuma Domestica Supplementation in Patients With Active Pulmonary Tuberculosis NCT07887724NA2 sites📍 Medan📍 Medan DINA KEUMALA SARI · Tests: CHANA STRIATA AND CURCUMA, Maltodextrin (Placebo) A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets NCT07170800Phase 27 sites📍 Wuhan📍 Changsha📍 Nanjing WestVac Biopharma Co., Ltd. · Tests: JDB0131 100mg, JDB0131 200mg, Delamanid (D) Improving the Outcomes of Children With Tuberculosis Through Innovative Diagnostics and Treatment Monitoring NCT06815588n/a1 site📍 Bucharest Research Center Borstel Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of RESP30TB in Tuberculosis NCT07073638Phase 21 site📍 Cape Town Thirty Respiratory Limited · Tests: RESP30TB, HRZE (Rifampicin, Isoniazid, Pyrazinamide, Ethambutol combination) Shortened Regimen for Drug-susceptible TB in Children NCT06253715Phase 39 sites📍 Chennai📍 Pune📍 Bandung Johns Hopkins University · Tests: Isoniazid, Rifampin, Pyrazinamide, Ethambutol, Rifapentine A PAN-USR TB Multi-Center Trial NCT06905522Phase 33 sites📍 Beijing📍 Shenzhen📍 Ürümqi Shenzhen Third People's Hospital · Tests: Bedaquiline (B), Sitafloxacin (S), Linezolid (L), Pyrazinamide (Z), Isoniazid (H) Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis NCT07525427Phase 213 sites📍 Durban📍 George📍 Johannesburg Gates Medical Research Institute · Tests: Bedaquiline, pretomanid and TBD09, Bedaquiline, pretomanid and TBD09, Bedaquiline, pretomanid and TBD09, Bedaquiline, p… A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients NCT05824871Phase 32 sites📍 Beijing📍 Beijing Shanghai Jiatan Pharmatech Co., Ltd · Tests: Sudapyridine, Bedaquiline Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TB NCT07672405Phase 212 sites📍 Wentworth📍 Port Elizabeth📍 Soshanguve Global Alliance for TB Drug Development · Tests: sorfequiline, Pretomanid, Linezolid Seoul National University Airway Registry NCT02527486n/a3 sites📍 Seongnam-si📍 Seoul📍 Seoul Seoul National University Hospital ATORvastatin in Pulmonary TUBerculosis NCT06199921Phase 28 sites📍 Zaria📍 Katsina📍 Keffi Obafemi Awolowo University Teaching Hospital · Tests: Atorvastatin 20mg, Atorvastatin 40mg, Atorvastatin 60mg, Fixed dose combination of Rifampicin (R) Isoniazid (H) Pyrazin… Novel Triple-dose Tuberculosis Retreatment Regimen NCT04260477Phase 31 site📍 Niamey Institute of Tropical Medicine, Belgium · Tests: 6EH³R³Z, 6EHRZ Paediatric Post-TB Pulmonary Rehab Study NCT07097961NA1 site📍 Kampala University of Iowa · Tests: Pulmonary Rehabilitation ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD) NCT07303699Phase 23 sites📍 Zaria📍 Katsina📍 Ile-Ife Obafemi Awolowo University Teaching Hospital · Tests: Atorvastatin 20 mg, Atorvastatin 40 mg, Atorvastatin 60 mg, Fixed dose combination of Rifampicin (R) Isoniazid (H) Pyra… A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease NCT06909799NA1 site📍 Fajara The Aurum Institute NPC · Tests: N-Acetyl Cysteine (NAC), Standard TB treatment Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T) NCT05401071Phase 2, Phase 36 sites📍 Guiyang📍 Kaili📍 Liupanshui Huashan Hospital · Tests: Short Regimen with Rifapentine 10mg/kg, Standardized Regimen, Short Regimen with Rifapentine 15mg/kg, Short Regimen wit… Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB NCT06114628Phase 211 sites📍 Chisinau📍 Cape Town📍 Cape Town University College, London · Tests: Ganfeborole, BTZ-043, Bedaquiline (B), Delamanid (D), Pretomanid (Pa) BRIGHT-Child TB: Short-Course Treatment for Non-Severe Pulmonary Tuberculosis in Children NCT07893444Phase 213 sites📍 Fuzhou📍 Guangzhou📍 Guiyang Huashan Hospital · Tests: 4-month FDC-based regimen, 3-month BDCZ regimen, Standard 6-month treatment regimen
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy